75 related articles for article (PubMed ID: 9613986)
1. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease.
Strom SS; Gu Y; Sigurdson AJ; Bailey NM; Amos CI; Spitz MR; Rodriguez MA; Liang JC
Leuk Lymphoma; 1998 Feb; 28(5-6):561-6. PubMed ID: 9613986
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients.
Strom SS; Hess KR; Sigurdson AJ; Spitz MR; Liang JC
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):291-3. PubMed ID: 9107435
[TBL] [Abstract][Full Text] [Related]
3. Sister chromatid exchange in malignant lymphomas.
Slavutsky I; de Vinuesa ML; Larripa I; de Pargament MM; de Salum SB
Cancer Genet Cytogenet; 1984 Oct; 13(2):153-8. PubMed ID: 6478441
[TBL] [Abstract][Full Text] [Related]
4. Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Caggana M; Kelsey KT
Carcinogenesis; 1991 Nov; 12(11):2141-5. PubMed ID: 1934301
[TBL] [Abstract][Full Text] [Related]
5. Studies on sister chromatid exchanges in patients with Hodgkin's disease.
Kadam PR; Advani SH; Bhisey AN
Cancer Genet Cytogenet; 1986 Jul; 22(3):265-74. PubMed ID: 3708557
[TBL] [Abstract][Full Text] [Related]
6. Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Sen P; Bailey NM; Hagemeister FB; Liang JC
Cancer Res; 1990 Feb; 50(3):558-62. PubMed ID: 1688733
[TBL] [Abstract][Full Text] [Related]
7. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
[TBL] [Abstract][Full Text] [Related]
8. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
9. Statistical models for analysis of cytogenetic biomarkers.
de Andrade M; Spitz MR; Wu X; Liang JC; Strom SS
J Investig Med; 2000 Jul; 48(4):281-6. PubMed ID: 10916287
[TBL] [Abstract][Full Text] [Related]
10. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
11. Mutational profiling of second primary lung cancers in patients who have received radiation for the treatment of Hodgkin's disease.
Bond DA; Dunavin N; Otterson GA
Cancer Invest; 2015 Mar; 33(3):86-8. PubMed ID: 25615851
[TBL] [Abstract][Full Text] [Related]
12. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
13. Location and incidence of chromosome and chromatid breaks in patients with Hodgkin's disease or testicular tumors.
Bilban-Jakopin C; Bilban M
Neoplasma; 2001; 48(2):122-6. PubMed ID: 11478692
[TBL] [Abstract][Full Text] [Related]
14. Structural chromosome aberrations in lymphocytes from children previously treated for Wilms' tumor or Hodgkin's disease.
Brøgger A; Kolmannskog S; Nicolaysen RB; Wesenberg F; Nygaard R
Pediatr Hematol Oncol; 1989; 6(2):95-103. PubMed ID: 2562012
[TBL] [Abstract][Full Text] [Related]
15. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
[TBL] [Abstract][Full Text] [Related]
17. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
[TBL] [Abstract][Full Text] [Related]
18. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
Liou SH; Lung JC; Chen YH; Yang T; Hsieh LL; Chen CJ; Wu TN
Cancer Res; 1999 Apr; 59(7):1481-4. PubMed ID: 10197617
[TBL] [Abstract][Full Text] [Related]
19. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
20. Elevated rates of sister chromatid exchange at chromosome ends.
Rudd MK; Friedman C; Parghi SS; Linardopoulou EV; Hsu L; Trask BJ
PLoS Genet; 2007 Feb; 3(2):e32. PubMed ID: 17319749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
